Your browser doesn't support javascript.
loading
COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022.
Björk, Jonas; Bonander, Carl; Moghaddassi, Mahnaz; Rasmussen, Magnus; Malmqvist, Ulf; Inghammar, Malin; Kahn, Fredrik.
Afiliação
  • Björk J; Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, Sweden.
  • Bonander C; Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden.
  • Moghaddassi M; School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Rasmussen M; Social Medicine and Global Health, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
  • Malmqvist U; Department of Clinical Sciences Lund, Section for Infection Medicine, Skåne University Hospital, Lund University, Lund, Sweden.
  • Inghammar M; Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden.
  • Kahn F; Department of Clinical Sciences Lund, Section for Infection Medicine, Skåne University Hospital, Lund University, Lund, Sweden.
Euro Surveill ; 27(18)2022 05.
Article em En | MEDLINE | ID: mdl-35514304

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Screening_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Screening_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia